Kangwei Century announced that the Mycoplasma pneumoniae nucleic acid and drug resistance mutation site test kit independently developed by Jiangsu Jianwei Diagnostic Technology Co., Ltd., a wholly-owned subsidiary of the company, obtained a Class III “Medical Device Registration Certificate” issued by the State Drug Administration. The registration certificate number is Guozheng No. 20263401716. The approval and entry into force date is August 17, 2026, and is valid until August 16, 2031. This product is used to qualitatively detect Mycoplasma pneumoniae DNA and drug resistance mutation sites in human throat swab samples in vitro. It is the 5th Class III registration certificate obtained by the company for respiratory disease testing.

Kangwei Century announced that the Mycoplasma pneumoniae nucleic acid and drug resistance mutation site test kit independently developed by Jiangsu Jianwei Diagnostic Technology Co., Ltd., a wholly-owned subsidiary of the company, obtained a Class III “Medical Device Registration Certificate” issued by the State Drug Administration. The registration certificate number is Guozheng No. 20263401716. The approval and entry into force date is August 17, 2026, and is valid until August 16, 2031. This product is used to qualitatively detect Mycoplasma pneumoniae DNA and drug resistance mutation sites in human throat swab samples in vitro. It is the 5th Class III registration certificate obtained by the company for respiratory disease testing.